U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445542) titled 'Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia' on Feb. 25.
Brief Summary: A Multi-center, Open-label, Observational Study to evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe after switching from Statin Monotherapy to Pitavastatin/Ezetimibe in patients with Hypercholesterolemia
Study Start Date: Dec. 18, 2021
Study Type: OBSERVATIONAL
Condition:
Hypercholesterolemia
Recruitment Status: COMPLETED
Sponsor: JW Pharmaceutical
Published by HT Digital Content Services with permission from Health Daily Digest....